• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Old Dogs, New Tricks: Revisiting Immune Modulatory Approaches for Myelodysplastic Syndromes.

作者信息

Götze Katharina S, Platzbecker Uwe

机构信息

Department of Medicine III, Technische Universität München, Munich, Germany.

Deutsche MDS Gruppe (D-MDS).

出版信息

Hemasphere. 2018 Nov 29;2(6):e162. doi: 10.1097/HS9.0000000000000162. eCollection 2018 Dec.

DOI:10.1097/HS9.0000000000000162
PMID:31723800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6745963/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e7/6745963/42595b3f7428/hs9-2-e162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e7/6745963/42595b3f7428/hs9-2-e162-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e7/6745963/42595b3f7428/hs9-2-e162-g001.jpg

相似文献

1
Old Dogs, New Tricks: Revisiting Immune Modulatory Approaches for Myelodysplastic Syndromes.老狗学新招：重新审视骨髓增生异常综合征的免疫调节方法
Hemasphere. 2018 Nov 29;2(6):e162. doi: 10.1097/HS9.0000000000000162. eCollection 2018 Dec.
2
Cytologic evaluation of primary and secondary myelodysplastic syndromes in the dog.犬原发性和继发性骨髓增生异常综合征的细胞学评估
Vet Clin Pathol. 2001;30(2):67-75. doi: 10.1111/j.1939-165x.2001.tb00261.x.
3
Primary myelodysplastic syndromes of dogs: a report of 12 cases.犬原发性骨髓增生异常综合征：12例报告
J Vet Intern Med. 2000 Sep-Oct;14(5):491-4. doi: 10.1892/0891-6640(2000)014<0491:pmsoda>2.3.co;2.
4
Infections in myelodysplastic syndromes.骨髓增生异常综合征中的感染。
Haematologica. 2012 Oct;97(10):1459-70. doi: 10.3324/haematol.2012.063420. Epub 2012 Jun 24.
5
Old dogs: new tricks, old tricks, or no tricks.老狗：新把戏、旧把戏，还是没把戏。
AJR Am J Roentgenol. 1997 Aug;169(2):349-50. doi: 10.2214/ajr.169.2.9273816.
6
Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.重新审视重组促红细胞生成素在骨髓增生异常综合征中的应用。
Clin Lymphoma. 2005 Jun;6(1):52-5. doi: 10.3816/clm.2005.n.029.
7
Immune modulatory agents in hematopoietic malignancies.造血系统恶性肿瘤的免疫调节药物。
Cancer Treat Rev. 2011;37 Suppl 1:S2-7. doi: 10.1016/j.ctrv.2011.05.004. Epub 2011 Jun 8.
8
Myelodysplastic syndromes: revisiting the role of the bone marrow microenvironment in disease pathogenesis.骨髓增生异常综合征：重新探讨骨髓微环境在疾病发病机制中的作用。
Int J Hematol. 2012 Jan;95(1):17-25. doi: 10.1007/s12185-011-1001-x. Epub 2012 Jan 6.
9
From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review.从免疫失调到骨髓增生异常综合征的治疗前景：综述
Diagnostics (Basel). 2021 Oct 26;11(11):1982. doi: 10.3390/diagnostics11111982.
10
Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.骨髓增生异常综合征中细胞毒性T细胞受体γδ T淋巴细胞在特定刺激下的激活。
Haematologica. 2008 Mar;93(3):381-9. doi: 10.3324/haematol.11812. Epub 2008 Feb 11.

引用本文的文献

1
Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Patients Aged Over 60 Years.60岁以上骨髓增生异常综合征患者的继发性急性髓系白血病
Cureus. 2023 Jun 8;15(6):e40124. doi: 10.7759/cureus.40124. eCollection 2023 Jun.
2
Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.骨髓间充质基质细胞衍生的细胞外基质在骨髓增生异常综合征中显示出糖胺聚糖结构改变和功能受损。
Front Oncol. 2022 Sep 8;12:961473. doi: 10.3389/fonc.2022.961473. eCollection 2022.
3
CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients.

本文引用的文献

1
Bifunctional PD-1 × αCD3 × αCD33 fusion protein reverses adaptive immune escape in acute myeloid leukemia.双功能 PD-1 × αCD3 × αCD33 融合蛋白逆转急性髓系白血病中的适应性免疫逃逸。
Blood. 2018 Dec 6;132(23):2484-2494. doi: 10.1182/blood-2018-05-849802. Epub 2018 Oct 1.
2
The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort.MDS 中免疫抑制治疗的应用：大型国际患者队列的临床结局及其预测因素。
Blood Adv. 2018 Jul 24;2(14):1765-1772. doi: 10.1182/bloodadvances.2018019414.
3
Clinical, molecular, and immunological responses to pembrolizumab treatment of synchronous melanoma and acute myeloid leukemia.
用于靶向高危成年骨髓增生异常综合征（MDS）患者的MDS克隆及免疫抑制性髓源性抑制细胞（MDSC）的CD123导向双特异性抗体
Front Aging. 2021 Sep 27;2:757276. doi: 10.3389/fragi.2021.757276. eCollection 2021.
4
Current challenges and unmet medical needs in myelodysplastic syndromes.骨髓增生异常综合征的当前挑战和未满足的医疗需求。
Leukemia. 2021 Aug;35(8):2182-2198. doi: 10.1038/s41375-021-01265-7. Epub 2021 May 28.
5
Acquired Pure Red Cell Aplasia Associated with Chronic Myelomonocytic Leukemia: Too Many of One, Not Enough of the Other.获得性纯红细胞再生障碍与慢性粒单核细胞白血病相关：一种细胞过多，另一种细胞不足。
Case Rep Oncol. 2020 Oct 15;13(3):1270-1274. doi: 10.1159/000508934. eCollection 2020 Sep-Dec.
帕博利珠单抗治疗黑色素瘤合并急性髓系白血病的临床、分子和免疫反应。
Blood Adv. 2018 Jun 12;2(11):1187-1190. doi: 10.1182/bloodadvances.2017014811.
4
Acute myeloid leukemia targets for bispecific antibodies.双特异性抗体的急性髓系白血病靶点
Blood Cancer J. 2017 Apr 14;7(4):e552. doi: 10.1038/bcj.2017.35.
5
The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications.人类髓系恶性肿瘤的微环境：新出现的概念和治疗意义。
Blood. 2017 Mar 23;129(12):1617-1626. doi: 10.1182/blood-2016-11-696070. Epub 2017 Feb 3.
6
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.自身免疫性疾病治疗与骨髓增生异常综合征和急性髓系白血病的关联。
JAMA Oncol. 2017 Jul 1;3(7):936-943. doi: 10.1001/jamaoncol.2016.6435.
7
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858.通过用Fc工程化CD33抗体BI 836858靶向髓系来源的抑制细胞（MDSCs）来改善低风险骨髓增生异常综合征（MDS）造血功能的新型治疗方法。
Leukemia. 2017 Oct;31(10):2172-2180. doi: 10.1038/leu.2017.21. Epub 2017 Jan 18.
8
Myeloid-Derived Suppressor Cells.髓系来源的抑制细胞
Cancer Immunol Res. 2017 Jan;5(1):3-8. doi: 10.1158/2326-6066.CIR-16-0297.
9
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia.骨髓增生异常综合征的遗传学：从克隆性造血到继发性白血病
Nat Rev Cancer. 2017 Jan;17(1):5-19. doi: 10.1038/nrc.2016.112. Epub 2016 Nov 11.
10
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype.NLRP3炎性小体作为骨髓增生异常综合征表型的驱动因素发挥作用。
Blood. 2016 Dec 22;128(25):2960-2975. doi: 10.1182/blood-2016-07-730556. Epub 2016 Oct 13.